Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Eledon Pharmaceuticals Inc ELDN

Healthcare Biotechnology
Eledon Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company’s lead investigational product is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target within the costimulatory CD40/CD40L cellular... see more

Recent & Breaking News (NDAQ:ELDN)

Eledon Pharmaceuticals to Release Third Quarter Financial Results on Thursday, November 11, 2021

GlobeNewswire November 1, 2021

CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement

GlobeNewswire October 19, 2021

Eledon Pharmaceuticals Announces Presentation on AT-1501 at the Virtual 2021 Northeast Amyotrophic Lateral Sclerosis Consortium

GlobeNewswire October 7, 2021

Eledon Pharmaceuticals Announces Upcoming Presentation on AT-1501 at the Virtual 2021 International Pancreas and Islet Transplantation Association Congress

GlobeNewswire October 5, 2021

Eledon Pharmaceuticals to Present at Two Investor Conferences in September

GlobeNewswire September 1, 2021

Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results

GlobeNewswire August 12, 2021

Eledon Pharmaceuticals to Release Second Quarter Financial Results on Thursday, August 12, 2021

GlobeNewswire August 2, 2021

Eledon Pharmaceuticals Receives Health Canada Approval to Commence Human Trials to Evaluate AT-1501 in Kidney Transplantation

GlobeNewswire July 26, 2021

Eledon Pharmaceuticals Appoints Jan Hillson, M.D., to its Board of Directors

GlobeNewswire July 2, 2021

Eledon Pharmaceuticals to Present at the Virtual Ladenburg Thalmann Healthcare Conference

GlobeNewswire June 29, 2021

Eledon Pharmaceuticals to Present at the 2021 Jefferies Virtual Healthcare Conference

GlobeNewswire May 18, 2021

Eledon Pharmaceuticals Reports First Quarter 2021 Operating and Financial Results

GlobeNewswire May 13, 2021

Eledon Pharmaceuticals Announces Upcoming Presentations on AT-1501 at the Virtual 2021 American Transplant Congress

GlobeNewswire May 5, 2021

Eledon Pharmaceuticals to Release First Quarter Financial Results on Thursday, May 13, 2021

GlobeNewswire May 4, 2021

Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation

GlobeNewswire April 26, 2021

Eledon Pharmaceuticals Continues to Bolster Leadership Team with Addition of Two More Key Executives

GlobeNewswire April 19, 2021

Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Operating and Financial Results

GlobeNewswire March 30, 2021

Eledon Pharmaceuticals to Release Fourth Quarter and Full-Year Financial Results on Tuesday, March 30

GlobeNewswire March 23, 2021

Eledon Pharmaceuticals Strengthens Leadership Team with Chief Medical Officer and Chief Financial Officer Hires

GlobeNewswire March 15, 2021

Eledon Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences Conference

GlobeNewswire March 2, 2021